Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease

Journal of Pediatrics

Volumn 133, Issue 6, 1998, Pages 777-781

  Hagstrom, J N ^a   Walter, J ^a   Bluebond Langner, R ^a   Amatniek, J C ^a   Manno, C S ^a   High, K A ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ADULT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CHILD; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; THROMBOEMBOLISM;

EID: 0031646469     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70150-7     Document Type: Article

References (29)

1. M David M Andrew Venous thromboembolic complications in children J Pediatr 123 1993 337 346
2. EE Weinmann EW Salzman Deep-vein thrombosis N Engl J Med 331 1994 1630 1642
3. M Andrew M David M Adams K Ali R Anderson D Barnard Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE Blood 83 1994 1251 1257
4. R Nuss T Hays M Manco-Johnson Childhood thrombosis Pediatrics 96 1995 291 294
5. B Dahlbäck Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 85 1995 607 614
6. AD Ma N Hagstrom KA High DB Cines Activated protein C resistance and factor V Leiden Adv Pathol 9 1996 311 328
7. T Koster FR Rosendaal H deRonde E Briët JP Vandenbroucke R Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506
8. FR Rosendaal T Koster J Vandenbroucke PH Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
9. VR Arruda JM Annichino-Bizzacchi FF Costa PH Reitsma Factor V Leiden (FVQ 506) is common in a Brazilian population Am J Hematol 49 1995 242 243
10. NJ Beauchamp ME Daly KK Hampton PC Cooper FE Preston IR Peake High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis Br J Haematol 88 1994 219 222
11. DH Lee PA Henderson MA Blajchman Prevalence of factor V Leiden in a Canadian blood donor population Can Med Assoc J 155 1996 285 289
12. K Kontula A Ylikorkala H Miettinen A Vuorio R Kauppinen-Makelin L Hamalainen Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction Thromb Haemost 73 1995 558 560
13. PD Forsyth G Dolan Activated protein C resistance in cases of cerebral infarction [letter] Lancet 345 1995 795
14. JG van der Bom ML Bots F Haverkate PE Slagboom P Meijer PT de Jong Reduced response to activated protein C is associated with increased risk for cerebrovascular disease Ann Intern Med 125 1996 265 269
15. J Emmerich O Poirier A Evans P Marques-Vidal D Arveiler G Luc Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance [letter] Lancet 345 1995 321
16. FR Rosendaal DS Siscovick SM Schwartz RK Beverly BM Psaty WT Longstreth Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women Blood 89 1997 2817 2821
17. RM Bertina BPC Koeleman T Koster FR Rosendaal RJ Dirnen H de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
18. MT Sifontes R Nuss LJ Jacobson JH Griffin MJ Manco-Johnson Thrombosis in otherwise well children with the factor V Leiden mutation J Pediatr 128 1996 324 328
19. U Nowak-Gottl R Schneppenheim H Vielhaber APC resistance in childhood thromboembolism: diagnosis and clinical aspects Semin Thromb Hemost 23 1997 253 258
20. U Nowak-Gottl HG Koch I Aschka B Kohlhase H Vielhaber G Kurlemann Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism Br J Haematol 92 1996 992 998
21. I Aschka V Aumann F Bergmann U Budde W Eberl S Sckhof-Donovan Prevalence of factor V Leiden in children with thrombo-embolism Eur J Pediar 155 1996 1009 1014
22. P Pottinger F Sigurdsson N Berliner Detection of the factor V Leiden mutation in a nonselected black population [letter] Blood 87 1996 2091
23. YL Ko TS Hsu SM Wu YS Ko CJ Chang SM Wang The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals Hum Genet 98 1996 176 177
24. M Devilat M Toso M Morales Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome Pediatr Neurol 9 1993 67 70
25. P Simioni PA Battistella P Drigo C Carollo A Girolami Childhood stroke associated with familial protein S deficiency Brain Dev 16 1994 241 245
26. U Nowak-Gottl R Strater A Dubbers K Oleszcuk-Raschke H Vielhaber Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene Blood Coagul Fibrinolysis 7 1996 684 688
27. V Ganesan H Kelsey J Cookson A Osborn FJ Kirkham Activated protein C resistance in childhood stroke [letter] Lancet 347 1996 260
28. G de Veber D MacGregor R Curtis P Vegh M Adams M Andrew Pre-thrombotic disorders in a consecutive cohort of infants and children with cerebral thromboembolism: Is testing worthwhile? [abstract] Thromb Haemost 178 suppl 1997 397
29. M Andrew Developmental hemostasis: relevance to thromboembolic complications in pediatric patients Thromb Haemost 74 1995 415 425